Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

NCT00716651 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Churg Strauss Syndrome

Interventions

DRUG: mepolizumab

Sponsor

University Hospital Schleswig-Holstein

Collaborators

[object Object]